p73 beta-expressing recombinant adenovirus: a potential anticancer agent. (Q40464378)

20 September 2017

title

p73 beta-expressing recombinant adenovirus: a potential anticancer agent. (English)

1 reference

20 September 2017

1 reference

Sanjeev Das

1

1 reference

20 September 2017

Srikanth Nama

series ordinal

2

1 reference

20 September 2017

Sini Antony

series ordinal

3

1 reference

20 September 2017

Kumaravel Somasundaram

series ordinal

4

1 reference

20 September 2017

publication date

1 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

417-426

1 reference

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Efficient growth inhibition of HPV 16 E6-expressing cells by an adenovirus-expressing p53 homologue p73beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

BRCA1 signals ARF-dependent stabilization and coactivation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Regulation of the p53 homolog p73 by adenoviral oncogene E1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

7 January 2021

p73 is transcriptionally regulated by DNA damage, p53, and p73

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

7 January 2021

Chemosensitivity linked to p73 function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

7 January 2021

Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

7 January 2021

Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

7 January 2021

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700803

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700803

1 reference

Dimensions Publication ID

20 September 2017

1046879404

0 references

1 reference